Can proton pump inhibitors be blamed for the rising incidence of esophageal cancer?

Gastroenterology. 2003 Dec;125(6):1912; author reply 1912-3. doi: 10.1053/j.gastro.2003.04.014.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Barrett Esophagus / pathology
  • Cell Division
  • Enzyme Inhibitors / adverse effects*
  • Esophageal Neoplasms / chemically induced*
  • Gastrins / blood
  • Humans
  • Proton Pump Inhibitors*
  • Receptor, Cholecystokinin B / physiology

Substances

  • Enzyme Inhibitors
  • Gastrins
  • Proton Pump Inhibitors
  • Receptor, Cholecystokinin B